Acute myeloid leukemia, multi-omics, classification, prognosis
inati-cel, CNCT19, adult, relapsed or refractory B-cell acute lymphoblastic leukaemia, CD19 CAR-T
Acute promyelocytic leukemia, PML::RARA fusion gene, measurable residual disease, the second consolidation therapy, relapse